The FDA has categorized this as a Class I recall, meaning the use of these devices could cause “serious injuries or death.”

Anjali Owens, MD, discussed the past, present and future of hypertrophic cardiomyopathy care in the United States. "What we are aiming to do is develop a minimum standard for assessments of patients with HCM so they are getting properly diagnosed and managed," she explained. 

The Hypertrophic Cardiomyopathy Association (HCMA) has helped guide and advance HCM care not only for patients, but also for hospitals and physicians. 

There have been 30 complaints so far about this issue, including 26 injuries and four deaths.

Researchers tracked data from nearly 7,000 TAVR patients for two years, focusing on all-cause mortality and heart failure hospitalizations.

A team of specialists from the Cleveland Clinic detailed the potential benefits—and risks—associated with following a ketogenic diet to address heart failure symptoms. The group recommended borrowing heavily from the Mediterranean diet and avoiding heavily processed "keto-friendly" products. 

New research, based on data from approximately 143 million patients, focused on prescriptions for heart failure, atrial fibrillation and other significant cardiac conditions. 

Researchers in Japan tracked BNP levels and bleeding events among more than 7,000 PCI patients. The group noted that managing heart failure in the first 30 days after PCI can help boost outcomes.